CVC and GBL launch €10.7bn bid for Recordati
A consortium led by CVC Capital Partners and Groupe Bruxelles Lambert has launched a voluntary cash tender offer to take Italian pharmaceutical group Recordati private, valuing the company at €10.7bn. The transaction, executed through the newly formed acquisition vehicle Respighi BidCo, signals a major strategic shift for the Milan-listed drugmaker as it seeks to shield its growth strategy from public…
GBL acquiring co-controlling stake in Rayner for €500m
Belgian-based, publicly traded investment holding company Groupe Bruxelles Lambert (GBL) has signed definitive agreements to acquire a 45% co-control stake in UK-based manufacturer of intraocular lenses and ophthalmic medical products Rayner. The transaction involves an equity investment of approximately €500m and will see GBL partnering with incumbent shareholder CVC Capital Partners and Rayner’s management team. Completion of the deal is…